federal_register: 2013-02293

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2013-02293 Draft Guidance for Industry on Enrichment Strategies for Clinical Trials To Support Approval of Human Drugs and Biological Products; Extension of Comment Period Notice The Food and Drug Administration (FDA) is extending the comment period for the draft guidance for industry entitled "Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products" that appeared in the Federal Register of December 17, 2012 (77 FR 74670). In the document, FDA announced the availability of this draft guidance and explained that the comment period would close on February 15, 2013. The Agency is taking this action to allow interested persons additional time to submit comments. 2013-02-04 2013 2 https://www.federalregister.gov/documents/2013/02/04/2013-02293/draft-guidance-for-industry-on-enrichment-strategies-for-clinical-trials-to-support-approval-of https://www.govinfo.gov/content/pkg/FR-2013-02-04/pdf/2013-02293.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is extending the comment period for the draft guidance for industry entitled "Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products" that appeared in the Federal...  

Links from other tables